← All trials
NCT06602063
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 31, 2024
- Primary completion
- Sep 30, 2029
- Completion date
- Sep 30, 2029
- First posted
- Sep 19, 2024
- Last posted
- Sep 19, 2024
- Enrollment
- 33
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Shanghai Gynecologic Oncology GroupLead sponsor
- Fudan UniversityCollaborator
- Huazhong University of Science and TechnologyCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.